State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| 1 |
Moderna
MRNA
|
+$2.55B |
| 2 |
Analog Devices
ADI
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Tesla
TSLA
|
+$1.09B |
| 5 |
Match Group
MTCH
|
+$979M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$1.84B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.43B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$612M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$528M |
| 5 |
Oracle
ORCL
|
+$435M |
Sector Composition
| 1 | Technology | 22.2% |
| 2 | Financials | 14.59% |
| 3 | Healthcare | 13.27% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Limoneira
LMNR
$280M
| $4.82M | ﹤0.01% |
298,037
-3,075
| -1% | -$49.7K |
|
3102
Treace Medical Concepts
TMCI
$470M
| $4.8M | ﹤0.01% |
178,527
+24,364
| +16% | +$655K |
|
3103
Amalgamated Financial
AMAL
$870M
| $4.8M | ﹤0.01% |
303,381
-3,319
| -1% | -$52.5K |
|
3104
Harvard Bioscience
HBIO
$19.7M
| $4.79M | ﹤0.01% |
685,695
-1,803
| -0.3% | -$12.6K |
|
3105
FS Bancorp
FSBW
$321M
| $4.78M | ﹤0.01% |
138,098
+15,988
| +13% | +$553K |
|
3106
Atlanticus Holdings
ATLC
$1.03B
| $4.78M | ﹤0.01% |
90,027
+5,813
| +7% | +$308K |
|
3107
Orrstown Financial Services
ORRF
$690M
| $4.76M | ﹤0.01% |
203,428
+10,422
| +5% | +$244K |
|
3108
Gold Fields
GFI
$34B
| $4.76M | ﹤0.01% |
585,598
-610,546
| -51% | -$4.96M |
|
3109
Lifecore Biomedical
LFCR
$291M
| $4.73M | ﹤0.01% |
512,664
-18,969
| -4% | -$175K |
|
|
PLYA
3110
DELISTED
Playa Hotels & Resorts
PLYA
| $4.73M | ﹤0.01% |
570,072
+7,209
| +1% | +$59.8K |
|
|
SQZ
3111
DELISTED
SQZ Biotechnologies Company
SQZ
| $4.72M | ﹤0.01% |
327,212
+41,284
| +14% | +$595K |
|
|
SMMF
3112
DELISTED
Summit Financial Group, Inc.
SMMF
| $4.69M | ﹤0.01% |
191,259
-1,972
| -1% | -$48.3K |
|
|
HBMD
3113
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $4.68M | ﹤0.01% |
230,966
+31,699
| +16% | +$643K |
|
|
ASAI
3114
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $4.68M | ﹤0.01% |
268,658
-9,282
| -3% | -$162K |
|
|
RXDX
3115
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $4.68M | ﹤0.01% |
197,266
+41,465
| +27% | +$983K |
|
3116
Distribution Solutions Group
DSGR
$1.46B
| $4.67M | ﹤0.01% |
186,682
+1,000
| +0.5% | +$25K |
|
|
CBAY
3117
DELISTED
Cymabay Therapeutics
CBAY
| $4.66M | ﹤0.01% |
1,276,967
-80,257
| -6% | -$293K |
|
3118
Eterna Therapeutics
ERNA
$10.6M
| $4.65M | ﹤0.01% |
1,666
+202
| +14% | +$564K |
|
3119
Comscore
SCOR
$32.2M
| $4.65M | ﹤0.01% |
59,571
+379
| +0.6% | +$29.6K |
|
3120
Korro Bio
KRRO
$323M
| $4.65M | ﹤0.01% |
13,162
+955
| +8% | +$337K |
|
|
VIRX
3121
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.63M | ﹤0.01% |
577,552
+93,330
| +19% | +$749K |
|
3122
CuriosityStream
CURI
$261M
| $4.62M | ﹤0.01% |
438,751
+44,454
| +11% | +$469K |
|
3123
United States Lime & Minerals
USLM
$3.67B
| $4.62M | ﹤0.01% |
191,310
+510
| +0.3% | +$12.3K |
|
3124
Ouster
OUST
$1.78B
| $4.62M | ﹤0.01% |
63,060
+5,428
| +9% | +$397K |
|
|
FRSX
3125
Foresight Autonomous Holdings
FRSX
$8.04M
| $4.59M | ﹤0.01% |
34,934
-1,630
| -4% | -$214K |
|